The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.88BCNY
1.03B · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
2.18BCNY
325.42M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-8.98%
vs Conglomerates peers
Updated Sep 21, 2026
Beta
0.2360x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-20.33%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
6.88BCNY
1.03B · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
5.86BCNY
875.25M · vs all stocks (USD)
Updated Sep 21, 2026
Forward P/E
100.86x
vs Conglomerates peers
Updated Sep 21, 2026
Price to Sales (TTM)
3.11x
vs Conglomerates peers
Updated Sep 21, 2026
Price to Book (MRQ)
2.82x
vs Conglomerates peers
Updated Sep 21, 2026
Enterprise to Revenue
2.69x
vs Conglomerates peers
Updated Sep 21, 2026
Enterprise to EBITDA
-111.62x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 36.36×.Updated Sep 21, 2026
Gross Margin
22.12%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 13.53%.Updated Sep 21, 2026
Profit Margin
-8.98%
vs Conglomerates peers
Updated Sep 21, 2026
Operating Margin
8.03%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Assets (TTM)
-1.23%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Equity (TTM)
-5.46%
vs Conglomerates peers
Updated Sep 21, 2026
Revenue (TTM)
2.18BCNY
325.42M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
2.28CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
-2.30%
vs Conglomerates peers
Updated Sep 21, 2026
Gross Profit (TTM)
294.85MCNY
44.03M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
161.18MCNY
24.07M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-195.78MCNY
-29.24M · vs all stocks (USD)
Updated Sep 21, 2026
Operating Cash Flow (TTM)
-29.48MCNY
-4.40M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-26.16MCNY
-3.91M · vs all stocks (USD)
Updated Sep 21, 2026
5-Year Average Dividend Yield
0.18%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Sep 21, 2026
Minority Interest (Equity)
774.46MCNYFY2025 · Dec 31, 2025
Revenue
2.14BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.67BCNYFY2025 · Dec 31, 2025
Gross Profit
472.18MCNYFY2025 · Dec 31, 2025
Operating Income
52.44MCNY
7.83M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-177.66MCNYFY2025 · Dec 31, 2025
Income Tax Expense
23.29MCNYFY2025 · Dec 31, 2025
Net Income
-200.94MCNYFY2025 · Dec 31, 2025
EBIT
-165.11MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
200.94MCNYFY2025 · Dec 31, 2025
Research & Development
43.67MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
76.62MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
59.35MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
43.82MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
12.55MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2228CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2228CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
959.47MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
959.47MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-200.94MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-12.83MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-361.77MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-418.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.99BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-200.94MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
61.42MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-142.49MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-79.75MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-56.22MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-102.40MCNYFY2025 · Dec 31, 2025
Sale of Investments
56.28MCNYFY2025 · Dec 31, 2025
Other Investing Activity
3.79MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-98.56MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
54.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-36.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-25.74MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-28.80MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-36.55MCNYFY2025 · Dec 31, 2025
Shares Outstanding
959.51MSharesUpdated Sep 21, 2026
Float Shares
687.00MSharesUpdated Sep 21, 2026
% Held by Insiders
34.29%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
1.34%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
1.86BCNY
277.90M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
1.94CNYUpdated Sep 21, 2026
Total Debt (MRQ)
185.88MCNY
27.76M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.0588x
vs Conglomerates peers
Updated Sep 21, 2026
Current Ratio (MRQ)
2.19x
vs Conglomerates peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
2.50CNYUpdated Sep 21, 2026
Total Assets
5.58BCNY
832.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.26BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.40BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.32BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
166.81MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.23BCNYFY2025 · Dec 31, 2025
Cash
1.98BCNYFY2025 · Dec 31, 2025
Cash Equivalents
53.91MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.06BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
73.13MCNYFY2025 · Dec 31, 2025
Accounts Receivable
195.82MCNYFY2025 · Dec 31, 2025
Inventory
1.19BCNYFY2025 · Dec 31, 2025
Accounts Payable
447.63MCNYFY2025 · Dec 31, 2025
Short-term Debt
116.40MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
43.74MCNYFY2025 · Dec 31, 2025
Long-term Debt
113.69MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
32.55MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
959.51MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.17BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.18BCNY
474.86M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.18CNYUpdated Sep 21, 2026
52-Week High
14.89CNYUpdated Sep 21, 2026
52-Week Change
-20.33%
vs all stocks
Updated Sep 21, 2026
Beta
0.2360x
vs all stocks
Updated Sep 21, 2026
50-Day MA
6.99CNYUpdated Sep 21, 2026
200-Day MA
9.19CNYUpdated Sep 21, 2026
Avg 10-Day Volume
20.09MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
24.38MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.2000CNYUpdated Sep 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.74: safe zoneNotable
Altman Z-Score: 2.74
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.